Capricor Therapeutics Announces Positive Results from its Interim Analysis in the HOPE-2 Trial to Treat Patients with Duchenne Muscular Dystrophy

July 15, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search